Our community narratives are driven by numbers and valuation.

Well, folks, my experience is personal, as such my hope is that experience will help you decide if what I did yesterday with Apple (AAPL) is for you as well: Mine was something few believe, robocalls on this iphone, before that the landlines associated with it-but for the last 8 years, I have been the robocall king with over 28,000 calls-it ruined pretty much everything, as imagine if you had a phone, but could rarely use it because there was so much spam, it never allowed an open line-much less clients to call in-it was an impossible scenario, and then, very quietly, Apple just solved this for everyone with an Iphone-call screening. Now, after all of this interference, that problem is somewhat simply solved by Apple, I cannot stress enough how little this is up played so far.Read more
By: The Forensic Analyst | Simply Wall St In the chaotic world of equity markets, price and value often diverge. But rarely do they divorce as violently as we are currently seeing with Ubisoft Entertainment SA (UBI.PA).Read more

At the beginning of 2023, Inter surprised those who did not follow the thesis in the market by disclosing its 60/30/30 Plan, which is a set of company guidelines for the year 2027. The company's goal is to reach 60 million customers, an efficiency index (expenses/revenues) of 30% and a return on equity (ROE) of 30%.Read more
Bintai Kinden Corporation Berhad is starting to look more interesting again, not just because of new contract wins, but because the company has already cleared a major overhang on sentiment. Bursa Malaysia approved Bintai’s upliftment from PN17, and the upliftment took effect from 9:00 a.m. on 27 February 2026.Read more
The Cigar Butt That Turned Out to Be a Full Havana There is a term Ben Graham used to describe beaten-down stocks with one last puff of value left in them: cigar butts. You pick them up off the street, take one free puff, and move on.Read more

Solaria delivered strong audited results for 2025, reporting €303M in revenue, €266M EBITDA and €137M net income. The company also reached 3.1 GW of installed capacity and continues to expand its renewable infrastructure platform.Read more
BridgeBio Pharma (BBIO) is currently trading at $71.61 USD on the NASDAQ as of March 26, 2026, marking a 4.5% daily gain following a series of clinical and commercial milestones. After successfully transitioning into a commercial-stage powerhouse in 2025, the company has entered 2026 with a "catalyst-rich" schedule.Read more
Eli Lilly already runs one of the fastest-growing drug businesses on earth, and its most powerful drug is not even approved yet. WHERE THE STOCK SITS TODAY The current price is around $907 (25/03/2026).Read more
TD Bank (TD) is currently trading at $94.30 USD ($130.32 CAD) on the NYSE as of March 26, 2026, showing resilience after a strong Q1 earnings beat. While the stock faced a multi-year headwind following the 2024 AML (Anti-Money Laundering) settlement, it has entered 2026 as a "recovery darling" in the financial sector.Read more

